Literature DB >> 7118247

Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus.

T N Kaul, R C Welliver, P L Ogra.   

Abstract

Antibody-dependent cell-mediated cytotoxicity (ADCC) was measured in nasopharyngeal secretions collected from 42 infants and young children at various intervals after primary or secondary infection with respiratory syncytial virus. ADCC was determined by specific immune release of 51Cr from respiratory syncytial virus-infected HEp-2 cell culture monolayers, with lymphocytes from adult volunteers as effector cells. Specific ADCC responses in nasopharyngeal secretions after primary infection were observed as early as 3 days after the onset of clinical symptoms, and peak activity was observed 14 to 29 days after the onset of illness. ADCC responses after reinfection were significantly greater in both the acute and convalescent phases (P less than 0.05) than were ADCC responses after primary infection. ADCC in secretions was mediated primarily by the immunoglobulin G isotype of respiratory syncytial virus antibody.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118247      PMCID: PMC347561          DOI: 10.1128/iai.37.2.492-498.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.

Authors:  C B Hall; R G Douglas; R L Simons; J M Geiman
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

2.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection.

Authors:  H W Kim; J O Arrobio; C D Brandt; B C Jeffries; G Pyles; J L Reid; R M Chanock; R H Parrott
Journal:  Am J Epidemiol       Date:  1973-09       Impact factor: 4.897

3.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

4.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

5.  Kinetics of the respiratory syncytial virus growth cycle in HeLa cells.

Authors:  S Levine; R Hamilton
Journal:  Arch Gesamte Virusforsch       Date:  1969

6.  Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.

Authors:  K McIntosh; J McQuillin; P S Gardner
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus.

Authors:  R Scott; M O de Landazuri; P S Gardner; J J Owen
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

8.  Augmentation of mouse natural killer cell activity by interferon and interferon inducers.

Authors:  J Y Djeu; J A Heinbaugh; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

9.  The immunologic response to infection with respiratory syncytial virus in infants.

Authors:  K McIntosh; H B Masters; I Orr; R K Chao; R M Barkin
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

10.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

View more
  10 in total

Review 1.  Detection, pathogenesis, and therapy of respiratory syncytial virus infections.

Authors:  R C Welliver
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 2.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

3.  Development of cell-mediated cytotoxic activity in the respiratory tract after experimental infection with respiratory syncytial virus.

Authors:  T Kumagai; D T Wong; P L Ogra
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

4.  Virus-induced complement activation and neutrophil-mediated cytotoxicity against respiratory syncytial virus (RSV).

Authors:  T N Kaul; H Faden; R Baker; P L Ogra
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

5.  Pretreatment with lipoteichoic acid sensitizes target cells to antibody-dependent cellular cytotoxicity in the presence of anti-lipoteichoic acid antibodies.

Authors:  D E Lopatin; R E Kessler
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

6.  Complement activation by respiratory syncytial virus-infected cells.

Authors:  K M Edwards; P N Snyder; P F Wright
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 7.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

Review 8.  Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.

Authors:  Elisabeth A van Erp; Willem Luytjes; Gerben Ferwerda; Puck B van Kasteren
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

9.  Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity.

Authors:  Nimesh Gupta; Jerome LeGoff; Soulaima Chamat; Severine Mercier-Delarue; Olivier Touzelet; Ultan F Power; Michel D Kazatchkine; Francois Simon; Sebastien Lacroix-Desmazes; Jagadeesh Bayry; Srinivas V Kaveri
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

10.  Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation.

Authors:  Elisabeth A van Erp; Anke J Lakerveld; Erik de Graaf; Mads D Larsen; Rutger M Schepp; Agnes L Hipgrave Ederveen; Inge Ml Ahout; Cornelis Am de Haan; Manfred Wuhrer; Willem Luytjes; Gerben Ferwerda; Gestur Vidarsson; Puck B van Kasteren
Journal:  Clin Transl Immunology       Date:  2020-02-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.